Nippon India and Bandhan Mutual Fund both buy into RHI Magnesita India on the same day
On September 22, 2026, both Nippon India Mutual Fund and Bandhan Mutual Fund bought into RHI Magnesita India on the very same day, at the exact same price of ₹360 a share. Same day, same price, two different fund houses — that's a strong clue to check whether the trades were part of something bigger. They were.
CMP ₹379.45 · Market cap ~₹7,830 crore · P/E ~42x (not meaningful — see below) (as of September 22, 2026; vs. Vesuvius India's ~31x, one of the closest listed peers)
It wasn't two funds independently spotting the same stock — it was one block deal
Same day, same price, two different fund houses — check for a block deal first. A block deal is a large, pre-arranged transaction where a buyer and seller agree on a price and quantity in advance, rather than each buyer separately deciding to buy in the continuous open market.
That's exactly what happened here. Dalmia Bharat Refractories sold 2,29,41,224 shares (11.11% of the company) worth roughly ₹826 crore through a block deal on the NSE on September 22, at ₹360 apiece — below the price the stock was trading at in the open market that day.
Four buyers picked up the entire block between them:
Buyer Shares Approx. value --------- SBI Mutual Fund 1,66,66,667 ~₹600 crore Bandhan Mutual Fund 27,77,777 ~₹100 crore Nippon India Mutual Fund 24,96,780 ~₹90 crore Clarus Capital 1 10,00,000 ~₹36 crore
Exchange bulk/block deal data independently confirmed the Nippon India and Bandhan legs — 24,96,780 and 27,77,777 shares respectively, both at ₹360, matching the reported ~₹90 crore and ~₹100 crore figures. SBI Mutual Fund was actually the largest buyer of the four, so this article focuses on the Nippon India and Bandhan legs.
The lesson: an identical price across two buyers on the same day is a block-deal signature, not independent conviction. When you see multiple institutions buying a stock at the exact same price on the same day, check for a block or bulk deal first — it usually means one seller distributed a large stake among several buyers in a single negotiated trade, not that several fund managers reached the same conclusion on their own.
The stock itself reacted well: it rose as much as ~7.8% intraday (touching roughly ₹397-398) before closing up a more modest ~3% for the day, at ₹379.45 on the BSE (₹378.60 on the NSE) — still comfortably above the ₹360 block-deal price. The four block-deal buyers picked up their shares at a discount to where the stock was trading in the open market.
What RHI Magnesita India actually makes
RHI Magnesita India manufactures refractory products — heat-resistant bricks, mixes, and flow-control systems that line the insides of furnaces, kilns, and other high-temperature industrial equipment so they can withstand extreme heat without cracking. Its main customers are steel companies, which continuously replace these linings to keep blast furnaces running, plus cement, glass, and aluminium makers. The company describes itself as having roughly 30% market share in India's refractories market.
It's a subsidiary of the global RHI Magnesita group, whose history dates back to 1834 (with the RHI lineage tracing to the Austro-American Magnesite Company, founded in Austria in 1908), which gives it access to product technology independent Indian competitors can't easily replicate. It's increasingly shifting toward a broader "4PRO" solutions model — combining refractory products with services, automation, robotics, and digital technologies, rather than just selling bricks and mixes transactionally (one example: its JSW robotic-maintenance solution is part of a 5-year contract).
The company's own history: it was incorporated on November 26, 2010 as Orient Refractories Limited. RHI later acquired a majority stake. In July 2021, the RHI Clasil and RHI India businesses were integrated into the already-listed Orient Refractories as part of a broader restructuring, and the combined entity was renamed RHI Magnesita India Limited — the company as it trades today.
FY26's headline loss, and why Q1 FY27 tells a different story
Metric FY26 (consolidated, full year) ------ Revenue ₹4,020 crore Net result -₹383 crore (net loss) EPS -₹18.54 ROE (3-year average) ~5.7% ROCE (FY26) 6.46%
Revenue held up, but the company booked a consolidated net loss for FY26. The important context: that loss was substantially driven by a ₹556 crore exceptional goodwill impairment — an accounting write-down of "goodwill" (the extra value recorded on the books when a company pays more to acquire a business than the identifiable value of its assets) tied to the older Dalmia Refractories acquisition. It's a non-cash charge, not a cash outflow, and it isn't evidence that day-to-day operations turned unprofitable.
The company's own Q1 FY27 earnings call (held August 2026, covering the quarter right after this loss-making year) confirms as much directly. Management stated the Dalmia goodwill has now been fully written off the balance sheet, is a non-cash item that sits below the EBITDA line, and confirmed no further goodwill impairment risk from that acquisition going forward. And the operating numbers for the new quarter look nothing like a struggling business:
- Q1 FY27 revenue: ₹1,014 crore (+6% YoY, +9% QoQ) - Q1 FY27 EBITDA (a common measure of operating profit before interest, tax, depreciation, and amortisation): ₹147 crore (+42% YoY), with EBITDA margin expanding to 14.5% from 10.8% a year earlier - Q1 FY27 profit after tax (PAT — what's left after all expenses and taxes): ₹65 crore, up from ₹35 crore in Q1 FY26 — an increase of about 86% - Cash and cash equivalents of ₹452 crore; management said the balance sheet remained net-cash positive
That's the pattern worth remembering from any single-year profit number: a large one-off item — a goodwill write-down here, or a CEO bonus elsewhere — can make a full year's headline result look far worse than the ongoing business actually performed.
Screener displays a P/E (price-to-earnings ratio — a common way of comparing a company's share price to how much profit it earns per share) of ~42x for the stock, but FY26 reported EPS was -₹18.54 — so a conventional P/E calculated on FY26 earnings isn't meaningful, and the ~42x figure shouldn't be read as the stock's valuation based on FY26 earnings. Always check the underlying profit number, not just the P/E ratio sitting next to it.
What management is promising next — and the risks alongside it
RHI Magnesita India's management laid out a detailed set of forward-looking targets on the Q1 FY27 call. These are the company's own stated plans and guidance, not verified facts or a promise — treat them as management's intentions, subject to change:
- FY27 EBITDA margin guidance: 13% — reaffirmed even after Q1 came in at 14.5%, because management expects some of that (war-related pricing surcharges, seasonal cement demand) to be temporary - FY27 volume growth guidance: 7-8%, walked back from an earlier 7-9% range after Q1 volumes underperformed the top end - Annual capex (money spent on long-term assets like plants, equipment, and mines): ₹80-100 crore for FY27, covering Dalmia plant modernisation and 4PRO robotics equipment - MINPRO joint venture with Khemka Refractories (RHIM holds 51%) — a new mineral-processing facility in Odisha, ₹35 crore initial investment over two years, targeted 8-10% EBITDA margin on that unit, payback under 3 years, production targeted for Q4 FY27 (Jan-Mar 2027) - Quartzite mines at Chiraipani and Bhikampali (acquired as part of the Dalmia deal) — all licenses received, opening targeted by end of Q2 FY27 (September 2026), with cost benefits expected from Q3 FY27 - Coke oven project — still at final negotiation stage with a public-sector customer, not yet a confirmed order, production start targeted September 2026, spanning a 14-16 month contract - Glass and silica projects — expected to close and begin execution in Q3-Q4 FY27 - SAIL's SMS4 blast furnace expansion (6-6.5 million tonnes capacity) — refractory procurement discussions expected to begin in 6-8 months; no order yet, but management has already met with SAIL - 4-5 new products from the global RHI Magnesita parent planned for India manufacturing within roughly a year - Leadership change: Pankaj Malhan appointed as new Managing Director and CEO (Parmod Sagar continues as Chairman), with a stated 5-pillar strategy of market outpacing, 4PRO expansion, digitisation, backward integration, and sustainability
Risks management itself flagged: magnesite raw-material price inflation of 6-8% in the two months before the call, with only partial cost pass-through possible; geopolitical disruption (the Ukraine-Russia war and Middle East conflict) suppressing exports and creating uncertainty around whether the "war surcharge" pricing benefit will persist; and rising industry-wide competitive intensity and excess capacity putting pressure on pricing across the sector.
How it stacks up against Vesuvius India, one of the closest listed peers
As of September 22, 2026:
RHI Magnesita India Vesuvius India --------- CMP ₹379.45 ~₹392.8 Market cap ~₹7,830 crore ~₹8,000 crore P/E ~42x (not meaningful — FY26 EPS negative) ~31x Latest profitability FY26 net loss (-₹383 cr, impairment-driven); Q1 FY27 PAT ₹65 cr, up ~86% YoY Profitable — Q2 CY26 (June 2026 quarter) net profit ₹58.5 crore Incorporated 2010 (as Orient Refractories) 1991
Vesuvius India, a subsidiary of the UK's Vesuvius plc and also a refractories maker, trades at a lower P/E while reporting a clean profit in its most recent quarter. On a simple current-year-loss basis, RHI Magnesita looks like the weaker of the two refractory makers — but its own most recent quarter (Q1 FY27) shows profit nearly doubling year-on-year, so the FY26 comparison alone understates how the business is actually trending right now.
None of this means the block-deal buyers got it wrong — SBI, Bandhan, and Nippon India's fund managers have access to far more diligence than a headline P/E ratio or a single year's loss number. But a retail investor reading "two mutual funds bought this stock" as a simple buy signal should know the fuller picture: a large shareholder exited through a negotiated block deal at a price below the market rate, the FY26 loss needs the goodwill-impairment context to be understood correctly, and the company's own guidance comes with real raw-material and geopolitical risks attached.
Note: I am not a SEBI-registered investment advisor. This article is for educational purposes only and is not investment advice. Please consult a registered financial advisor before making investment decisions.
Sources
- https://economictimes.indiatimes.com/markets/stocks/news/rhi-magnesita-block-deal-dalmia-bharat-refractories-divests-11-11-stake-for-rs-826-crore-sbi-mf-bandhan-mf-among-buyers/articleshow/134415677.cms - https://www.business-standard.com/markets/news/block-deal-impact-rhi-magnesita-gains-8-transaction-valued-at-826-cr-1260922002321.html - https://www.screener.in/company/RHIM/consolidated/ - https://www.screener.in/company/VESUVIUS/consolidated/ - https://financialfilings.com/filings/rhi-magnesita-india-limited/annual-report/2026/59475677/ - https://www.goodreturns.in/company/rhi-magnesita-india/bse-price-history-17028419.html - https://www.realcase.in/news/rhim-to-hold-investor-meet-on-sep-28-2026 - RHI Magnesita India Q1 FY27 earnings call transcript (filed with NSE, August 18, 2026)